Cannabis Brief: Major Retail Stores Clearing Shelves to Carry CBD Infused Products

Palm Beach FL – April 17, 2019 –  The projections for the legal & CBD cannabis markets seem to get higher with every new arrival… and big box and  brick & mortar retailers  of all sizes have taken notice. The legal marijuana and CBD markets numbers are increasingly optimistic. Legal Marijuana: “Today, the U.S. is the […]

Image Protect Prepares for the Debut of its Virtual Image Marketplace, Monetizing its Advanced Technology in the Rapidly Expanding $50 Billion In-Image Ad Market

Set to Capitalize on the Paradigm Shift, the Company’s Revolutionary Fotofy Enabled Platform Structures for Official Launch on August 1, 2019   San Clemente, CA, April 17, 2019 – Image Protect Inc. (OTCPK:IMTL) (imageprotect.com) (“Image Protect” or the “Company”), a global leader in the end-to-end copyright infringement sector, is pleased to announce that the Company […]

Biotech Brief: Optimism Rising For Cancer Treatment Advancements In 2019

Palm Beach, FL – April 17, 2019 – The American Association for Cancer Research (AARC) recently released an article that interviewed Nobel Laureate, Fellow of the AACR Academy, and immunotherapy pioneer James P. Allison, PhD  and  AACR President-elect and precision medicine expert Elaine Mardis, PhD about what they see happening in 2019. The article said: “In […]

CROP TO ENTER OKLAHOMA MEDICAL CANNABIS MARKET

Vancouver, BC – April 17, 2019 – CROP INFRASTRUCTURE CORP. (CSE: CROP) (OTCPK: CRXPF) (Frankfurt: 2FR) announced today that it has identified multiple Tenants for a roll out strategy to enter Oklahoma to target the Medical Cannabis market focusing on Cultivation, Extraction and Retail infrastructure. CROP will own 49% of the newly incorporated company.   […]

Moleculin Announces Significant Discovery in Lung Cancer Models

Annamycin Found to be Active Against Metastatic Lung Cancer in Pre-Clinical Testing   Houston, TX – April 17, 2018 – Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced that its ongoing sponsored research at The University […]